Search Newsletters

Pharma

Transforming health through business and innovation.

Pharma stocks slump as Pfizer and Merck report earnings

ByCatherine Baab

Big Pharma poured billions into AI drug discovery. It could soon pay off

ByCatherine Arnst

Eli Lilly is eyeing an off-ramp for patients to switch from weight loss injections to pills

ByCatherine Arnst

A federal panel picked by RFK Jr. voted to end Hepatitis B vaccines for newborns

ByCatherine Arnst

'There's never been a drug with this range': The weight loss boom is just getting started

ByCatherine Arnst

Eli Lilly discounts Zepbound as price war over weight loss drugs heats up

Ozempic is coming to Thanksgiving

ByCatherine Arnst

Eli Lilly hit $1 trillion, propelled by weight-loss drug boom

ByHannah Parker

Ozempic is getting cheaper as Novo Nordisk rushes to undercut Eli Lilly

ByCatherine Arnst

1 in 5 U.S. adults say they've taken Ozempic or similar drugs, survey finds

ByCatherine Arnst

Eli Lilly and Novo Nordisk cut deals with Trump to lower weight loss drug prices

ByCatherine Arnst

Kimberly-Clark is buying Tylenol maker Kenvue for more than $48 billion

UnitedHealth's 'recovery' reveals what's really sick in American healthcare

ByCatherine Baab

Soaring drug prices are leaving inflation in the dust

ByCatherine Arnst

Trump says Ozempic will get much cheaper. Novo Nordisk and Eli Lilly shares tumble

ByCatherine Arnst

Wegovy and Zepbound should be the go-to obesity treatment, medical group says

ByCatherine Arnst

Tylenol maker's stock bounces back after Trump baselessly links painkiller to autism

What is TrumpRx? White House mulls government prescription drug website

Health insurers say they'll keep covering vaccines as a political fight widens

ByCatherine Arnst

Trump's ongoing battle with the pharma industry shows no signs of easing

ByCatherine Arnst